TradingKey

关于 Avanos Medical Inc 公司

Avanos Medical, Inc. 是一家专注于提供解决方案的医疗器械公司。该公司提供医疗保健需求，例如为患者从医院到家中提供营养，减少阿片类药物的使用，同时帮助患者从手术过渡到康复。该公司的业务分为一个部门，通过位于美国和墨西哥的制造工厂向全球医疗保健提供者和患者提供医疗器械产品。其消化健康产品包括 MIC-KEY 肠内喂养管、Corpak 患者喂养解决方案和 NeoMed 新生儿和儿科喂养解决方案。该公司的急性疼痛产品包括 ON-Q 和 ambIT 手术止痛泵以及 Game Ready 冷敷和加压治疗系统。该公司的介入性疼痛解决方案包括 COOLIEF 疼痛治疗和 OrthogenRxs 膝关节骨关节炎止痛注射产品。

公司简介

公司代码AVNS

公司名称Avanos Medical Inc

上市日期Oct 21, 2014

CEOMr. David Pacitti

员工数量2227

证券类型Ordinary Share

年结日Oct 21

公司地址5405 Windward Parkway

城市ALPHARETTA

上市交易所NYSE Consolidated

国家United States of America

邮编30004

电话18444282667

网址https://avanos.com/

公司代码AVNS

上市日期Oct 21, 2014

CEOMr. David Pacitti

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. David Pacitti

Chief Executive Officer

242.05K

--

Ms. Mojirade James

Senior Vice President, General Counsel, Secretary

132.93K

+13.98%

Mr. Gary D. Blackford

Independent Non-Executive Chairman of the Board

71.59K

--

Mr. Patrick J. O'Leary

Independent Director

66.64K

--

Dr. Julie Ann Shimer, Ph.D.

Independent Director

62.09K

--

Mr. Sigfrido (Sig) Delgado

Senior Vice President - Integrated Supply Chain

44.12K

+58.59%

Mr. Jason M. Pickett

Interim Chief Financial Officer

--

Mr. Kerr W. Holbrook

Senior Vice President, Chief Commercial Officer

--

Ms. Indrani L. Franchini, J.D.

Independent Director

--

Dr. Lisa C. Egbuonu-Davis, M.D.

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Mr. David Pacitti

Chief Executive Officer

242.05K

--

Ms. Mojirade James

Senior Vice President, General Counsel, Secretary

132.93K

+13.98%

Mr. Gary D. Blackford

Independent Non-Executive Chairman of the Board

71.59K

--

Mr. Patrick J. O'Leary

Independent Director

66.64K

--

Dr. Julie Ann Shimer, Ph.D.

Independent Director

62.09K

--

Mr. Sigfrido (Sig) Delgado

Senior Vice President - Integrated Supply Chain

44.12K

+58.59%

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Enteral feeding

74.50M

44.48%

Radiofrequency ablation

31.70M

18.93%

Neonate solutions

26.60M

15.88%

Surgical pain and recovery

24.50M

14.63%

Corporate & Other

10.20M

6.09%

地区USD

名称

营收

占比

North America

130.80M

78.09%

Europe, Middle East and Africa

23.70M

14.15%

Asia Pacific and Latin America

13.00M

7.76%

业务

地区

业务USD

名称

营收

占比

Enteral feeding

74.50M

44.48%

Radiofrequency ablation

31.70M

18.93%

Neonate solutions

26.60M

15.88%

Surgical pain and recovery

24.50M

14.63%

Corporate & Other

10.20M

6.09%

股东统计

更新时间: 5月16日周五

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.84%

The Vanguard Group, Inc.

9.66%

T. Rowe Price Investment Management, Inc.

8.13%

Dimensional Fund Advisors, L.P.

5.61%

Armistice Capital LLC

4.32%

Other

58.44%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.84%

The Vanguard Group, Inc.

9.66%

T. Rowe Price Investment Management, Inc.

8.13%

Dimensional Fund Advisors, L.P.

5.61%

Armistice Capital LLC

4.32%

Other

58.44%

股东类型

持股股东

占比

Investment Advisor

49.49%

Investment Advisor/Hedge Fund

26.84%

Hedge Fund

12.65%

Individual Investor

3.85%

Research Firm

2.44%

Pension Fund

1.13%

Family Office

1.11%

Bank and Trust

0.48%

Sovereign Wealth Fund

0.41%

Other

1.60%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

602

45.07M

97.47%

-3.44M

2025Q1

625

45.60M

98.62%

-4.71M

2024Q4

608

45.85M

99.67%

-4.42M

2024Q3

597

45.57M

99.16%

-4.09M

2024Q2

599

45.09M

98.21%

-5.57M

2024Q1

607

46.20M

99.99%

-5.04M

2023Q4

613

46.52M

100.18%

-4.77M

2023Q3

611

46.28M

98.90%

-3.96M

2023Q2

610

46.69M

100.04%

-2.11M

2023Q1

634

46.30M

99.34%

-1.85M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

6.40M

13.84%

-218.21K

-3.30%

Mar 31, 2025

The Vanguard Group, Inc.

5.29M

11.43%

-27.57K

-0.52%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

3.76M

8.13%

+746.26K

+24.78%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

2.60M

5.61%

+17.04K

+0.66%

Mar 31, 2025

Armistice Capital LLC

2.00M

4.32%

+2.00M

--

Mar 31, 2025

Brown Advisory

1.93M

4.18%

+26.07K

+1.37%

Mar 31, 2025

State Street Global Advisors (US)

1.93M

4.17%

-30.80K

-1.57%

Mar 31, 2025

Paradice Investment Management LLC

1.29M

2.78%

-7.17K

-0.55%

Mar 31, 2025

D. E. Shaw & Co., L.P.

1.09M

2.35%

+594.35K

+120.16%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.08M

2.33%

+35.44K

+3.40%

Mar 31, 2025

持股ETF

更新时间: 8月2日周六

机构名称

占比

SPDR S&P Health Care Equipment ETF

0.96%

Invesco S&P SmallCap 600 Pure Value ETF

0.53%

Invesco S&P SmallCap Health Care ETF

0.4%

Harbor Human Capital Factor US Small Cap ETF

0.34%

Pacer US Small Cap Cash Cows Growth Leaders ETF

0.28%

Royce Quant Small-Cap Quality Value ETF

0.26%

Vanguard US Value Factor ETF

0.17%

SPDR SSGA US Small Cap Low Volatility Index ETF

0.15%

Pacer US Small Cap Cash Cows ETF

0.14%

Fidelity Enhanced Small Cap ETF

0.14%

SPDR S&P Health Care Equipment ETF

占比0.96%

Invesco S&P SmallCap 600 Pure Value ETF

占比0.53%

Invesco S&P SmallCap Health Care ETF

占比0.4%

Harbor Human Capital Factor US Small Cap ETF

占比0.34%

Pacer US Small Cap Cash Cows Growth Leaders ETF

占比0.28%

Royce Quant Small-Cap Quality Value ETF

占比0.26%

Vanguard US Value Factor ETF

占比0.17%

SPDR SSGA US Small Cap Low Volatility Index ETF

占比0.15%

Pacer US Small Cap Cash Cows ETF

占比0.14%

Fidelity Enhanced Small Cap ETF

占比0.14%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Avanos Medical Inc

11.281USD

Avanos Medical Inc

11.281

概览

公司

财务